 Connection
Shin Tsunekawa to Female
This is a "connection" page, showing publications Shin Tsunekawa has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.069 |
|
|
|
-
Yamada Y, Himeno T, Tsuboi K, Shibata Y, Kawai M, Asada-Yamada Y, Hayashi Y, Asano-Hayami E, Hayami T, Ishida Y, Ejima Y, Motegi M, Asano S, Kato M, Nagao E, Nakai-Shimoda H, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakayama T, Kamei M, Nakamura J, Kamiya H. Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy. J Diabetes Investig. 2021 Aug; 12(8):1430-1441.
Score: 0.010
-
Kawai M, Himeno T, Shibata Y, Hirai N, Asada-Yamada Y, Asano-Hayami E, Ejima Y, Kasagi R, Nagao E, Sugiura-Roth Y, Nakai-Shimoda H, Nakayama T, Yamada Y, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H. Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes. J Diabetes Investig. 2021 Jul; 12(7):1236-1243.
Score: 0.010
-
Kamiya H, Shibata Y, Himeno T, Tani H, Nakayama T, Murotani K, Hirai N, Kawai M, Asada-Yamada Y, Asano-Hayami E, Nakai-Shimoda H, Yamada Y, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Baba M, Nakamura J. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model. J Diabetes Investig. 2021 Apr; 12(4):583-591.
Score: 0.010
-
Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M. TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets. J Clin Invest. 2019 07 29; 129(9):3578-3593.
Score: 0.009
-
Shibata Y, Himeno T, Kamiya T, Tani H, Nakayama T, Kojima C, Sugiura-Roth Y, Naito E, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H. Validity and reliability of a point-of-care nerve conduction device in diabetes patients. J Diabetes Investig. 2019 Sep; 10(5):1291-1298.
Score: 0.009
-
Okawa T, Tsunekawa S, Seino Y, Hamada Y, Oiso Y. Deceptive HbA1c in a patient with pure red cell aplasia. Lancet. 2013 Jul 27; 382(9889):366.
Score: 0.006
-
Miura Y, Yamamoto N, Tsunekawa S, Taguchi S, Eguchi Y, Ozaki N, Oiso Y. Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. Diabetes Care. 2005 Mar; 28(3):757-8.
Score: 0.003
-
Ikemoto M, Tsunekawa S, Awane M, Fukuda Y, Murayama H, Igarashi M, Nagata A, Kasai Y, Totani M. A useful ELISA system for human liver-type arginase, and its utility in diagnosis of liver diseases. Clin Biochem. 2001 Sep; 34(6):455-61.
Score: 0.003
-
Kawahata K, Misaki Y, Komagata Y, Setoguchi K, Tsunekawa S, Yoshikawa Y, Miyazaki J, Yamamoto K. Altered expression level of a systemic nuclear autoantigen determines the fate of immune response to self. J Immunol. 1999 Jun 01; 162(11):6482-91.
Score: 0.002
-
Kitai T, Shinohara H, Hatano E, Sato S, Kanazawa A, Tsunekawa S, Yamamoto M, Yamaoka Y, Uemoto S, Inomata Y, Tanaka K, Tanaka A. Postoperative monitoring of the oxygenation state of the graft liver in cases with hepatopulmonary syndrome. Transplantation. 1996 Dec 15; 62(11):1676-8.
Score: 0.002
-
Ikemoto M, Ishida A, Tsunekawa S, Ozawa K, Kasai Y, Totani M, Ueda K. Enzyme immunoassay of liver-type arginase and its potential clinical application. Clin Chem. 1993 May; 39(5):794-9.
Score: 0.002
-
Mukawa A, Kamitsuma Y, Tsunekawa S, Tanaka N. Report on a long-term trial of CYBEST Model 2 for prescreening for squamous cell carcinoma of the uterine cervix. Anal Cell Pathol. 1989 Aug; 1(4):225-33.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|